BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25800567)

  • 1. [Isolation and identification of CD133 positive and negative cells from human lung cancer and screening of the differential genes between the positive and negative cells].
    Zheng S; Li S; Wang H; Xie X; Zhang Y
    Zhongguo Fei Ai Za Zhi; 2015 Mar; 18(3):123-30. PubMed ID: 25800567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Isolation and characterization of brain tumor stem cells in human medulloblastoma].
    Li MC; Deng YW; Wu J; Chen FH; Liu JF; Fang JS
    Ai Zheng; 2006 Feb; 25(2):241-6. PubMed ID: 16480595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD133 is a temporary marker of cancer stem cells in small cell lung cancer, but not in non-small cell lung cancer.
    Cui F; Wang J; Chen D; Chen YJ
    Oncol Rep; 2011 Mar; 25(3):701-8. PubMed ID: 21174061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The study of the tumor stem cell properties of CD133+CD44+ cells in the human lung adenocarcinoma cell line A549.
    Zhang HZ; Lin XG; Hua P; Wang M; Ao X; Xiong LH; Wu C; Guo JJ
    Cell Mol Biol (Noisy-le-grand); 2010 Sep; 56 Suppl():OL1350-8. PubMed ID: 20937222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction.
    Tirino V; Camerlingo R; Bifulco K; Irollo E; Montella R; Paino F; Sessa G; Carriero MV; Normanno N; Rocco G; Pirozzi G
    Cell Death Dis; 2013 May; 4(5):e620. PubMed ID: 23640462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary screening and identification of stem cell-like sphere clones in a gallbladder cancer cell line GBC-SD.
    Yin BB; Wu SJ; Zong HJ; Ma BJ; Cai D
    J Zhejiang Univ Sci B; 2011 Apr; 12(4):256-63. PubMed ID: 21462380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD133(+) gallbladder carcinoma cells exhibit self-renewal ability and tumorigenicity.
    Shi CJ; Gao J; Wang M; Wang X; Tian R; Zhu F; Shen M; Qin RY
    World J Gastroenterol; 2011 Jun; 17(24):2965-71. PubMed ID: 21734809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of RNA interference inhibition to expression of CD133 on tumor cell biological characteristics in KATO-III CD133(+) cells of human gastric cancer].
    Wang SL; Yu JW; Cai C; Lu RQ; Wu JG; Ni XC; Jiang BJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Sep; 16(9):889-94. PubMed ID: 24062002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells.
    Kryczek I; Liu S; Roh M; Vatan L; Szeliga W; Wei S; Banerjee M; Mao Y; Kotarski J; Wicha MS; Liu R; Zou W
    Int J Cancer; 2012 Jan; 130(1):29-39. PubMed ID: 21480217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD133+ cancer stem-like cells in small cell lung cancer are highly tumorigenic and chemoresistant but sensitive to a novel neuropeptide antagonist.
    Sarvi S; Mackinnon AC; Avlonitis N; Bradley M; Rintoul RC; Rassl DM; Wang W; Forbes SJ; Gregory CD; Sethi T
    Cancer Res; 2014 Mar; 74(5):1554-65. PubMed ID: 24436149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep-2 cell line.
    Wei XD; Zhou L; Cheng L; Tian J; Jiang JJ; Maccallum J
    Head Neck; 2009 Jan; 31(1):94-101. PubMed ID: 18853445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes of differentiation and gene expression of CD133+ cells in human umbilical cord blood induced by SCF and bFGF].
    Zhang J; Zhu JS; Li QR; DU Y; Yang B; Li GX; Hu X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):146-50. PubMed ID: 20137136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latexin inhibits the proliferation of CD133+ miapaca-2 pancreatic cancer stem-like cells.
    Xue ZX; Zheng JH; Zheng ZQ; Cai JL; Ye XH; Wang C; Sun WJ; Zhou X; Lu MD; Li PH; Cai ZZ
    World J Surg Oncol; 2014 Dec; 12():404. PubMed ID: 25551472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).
    Choijamts B; Jimi S; Kondo T; Naganuma Y; Matsumoto T; Kuroki M; Iwasaki H; Emoto M
    Stem Cells; 2011 Oct; 29(10):1485-95. PubMed ID: 21919130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subpopulation of small-cell lung cancer cells expressing CD133 and CD87 show resistance to chemotherapy.
    Kubo T; Takigawa N; Osawa M; Harada D; Ninomiya T; Ochi N; Ichihara E; Yamane H; Tanimoto M; Kiura K
    Cancer Sci; 2013 Jan; 104(1):78-84. PubMed ID: 23066953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment.
    Bertolini G; Roz L; Perego P; Tortoreto M; Fontanella E; Gatti L; Pratesi G; Fabbri A; Andriani F; Tinelli S; Roz E; Caserini R; Lo Vullo S; Camerini T; Mariani L; Delia D; Calabrò E; Pastorino U; Sozzi G
    Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16281-6. PubMed ID: 19805294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Isolation and identification of cancer stem cells from primary human ovarian cancer tissues].
    Lin S; Long HX; Xiang T; Zhu B; Xie RK
    Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):896-9. PubMed ID: 22340097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Identification and isolation of cancer stem cells from A549 cells].
    Xia H; Yu C; Zhang W; Zhang B; Zhao Y; Fang F
    Zhongguo Fei Ai Za Zhi; 2013 Aug; 16(8):400-4. PubMed ID: 23945242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologic characteristics of the side population of human small cell lung cancer cell line H446.
    Wang B; Yang H; Huang YZ; Yan RH; Liu FJ; Zhang JN
    Chin J Cancer; 2010 Mar; 29(3):254-60. PubMed ID: 20193106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological significance of cancer stem cells marked by CD133 and KAI1/CD82 expression in laryngeal squamous cell carcinoma.
    Yu L; Zhou L; Wu S; Gong X; Feng Z; Ma L; Zhu B; Yao N; Wang D; Dong H
    World J Surg Oncol; 2014 Apr; 12():118. PubMed ID: 24758564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.